DD45721A - - Google Patents
Info
- Publication number
- DD45721A DD45721A DD45721DA DD45721A DD 45721 A DD45721 A DD 45721A DD 45721D A DD45721D A DD 45721DA DD 45721 A DD45721 A DD 45721A
- Authority
- DD
- German Democratic Republic
Links
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD45721A true DD45721A (en) |
Family
ID=245756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD45721D DD45721A (en) |
Country Status (1)
| Country | Link |
|---|---|
| DD (1) | DD45721A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4585796A (en) * | 1982-08-10 | 1986-04-29 | Hoffmann-La Roche Inc. | Novel phenethanolamines |
| US4652679A (en) * | 1982-05-14 | 1987-03-24 | Hoffmann-La Roche Inc. | Aziridine and phenethanolamine derivatives having antiobesity and anti-hyperglycaemic acitivity |
| US10288602B2 (en) | 2013-01-08 | 2019-05-14 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatement |
-
0
- DD DD45721D patent/DD45721A/xx unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4652679A (en) * | 1982-05-14 | 1987-03-24 | Hoffmann-La Roche Inc. | Aziridine and phenethanolamine derivatives having antiobesity and anti-hyperglycaemic acitivity |
| US4585796A (en) * | 1982-08-10 | 1986-04-29 | Hoffmann-La Roche Inc. | Novel phenethanolamines |
| US10288602B2 (en) | 2013-01-08 | 2019-05-14 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatement |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3705233A (en) | Phenylaminoethanol derivatives | |
| EP2330124B1 (en) | Hybrid polypeptides with selectable properties | |
| US4585796A (en) | Novel phenethanolamines | |
| RS62895B1 (en) | Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia | |
| LU91651I9 (en) | ||
| YU79200A (en) | Therapeutic biaryl derivatives | |
| NL7614329A (en) | CARBOSTYRIL DERIVATIVES AND PROCESS FOR PREPARING THEM. | |
| US10288602B2 (en) | Screening method, a kit, a method of treatment and a compound for use in a method of treatement | |
| AU2007286051A1 (en) | Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure | |
| EP3681857A1 (en) | Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia | |
| EP2009109A1 (en) | G protein-related kinase mutants in essential hypertension | |
| DK118827B (en) | Process for the preparation of 1- (4-hydroxyphenyl) -2- [2- (4-hydroxyphenyl) -ethylamino] -propanol or salts thereof. | |
| US4652679A (en) | Aziridine and phenethanolamine derivatives having antiobesity and anti-hyperglycaemic acitivity | |
| MC1192A1 (en) | BENZIMIDAZOLE DERIVATIVES |